Monitor the outcome of the vote on the share increase, as it could lead to future dilution. The advisory vote on executive compensation is non-binding but may signal shareholder sentiment.
Price Chart
Executive Summary
NextCure, Inc. filed a definitive proxy statement for its 2026 Annual Meeting, where shareholders will vote on the election of two Class I Directors, ratification of the independent auditor, approval of executive compensation, and an amendment to increase shares authorized under the 2019 Omnibus Incentive Plan.
Key Financial Metrics
Key Facts
- Annual Meeting scheduled for June 18, 2026.
- Two Class I Directors (Anne Borgman, M.D. and John G. Houston, Ph.D.) are up for election.
- Shareholders will vote on ratifying Ernst & Young LLP as the independent auditor.
- Shareholders will vote to approve executive compensation on an advisory basis.
- Shareholders will vote to approve an amendment increasing the number of shares authorized under the 2019 Omnibus Incentive Plan.
Financial Impact
The share increase could lead to dilution if new shares are issued, but the magnitude is not specified in the filing.
Risk Factors
- Potential dilution from the increase in authorized shares.
- Shareholder dissent on executive compensation could lead to governance issues.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-048606 |
| Document: 0001104659-26-048606-index-headers.html | 0001104659-26-048606 |
| Document: 0001104659-26-048606-index.html | 0001104659-26-048606 |
| Document: 0001104659-26-048606.txt | 0001104659-26-048606 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | SC 13G | $5.44 | awaiting T+60 | — | $5.22 (−3.95%) |
Sep 25, 2026 4w ago | 425 | $5.08 | awaiting T+60 | — | $5.22 (+2.85%) |
Sep 25, 2026 4w ago | 8-K | $5.08 | awaiting T+60 | — | $5.22 (+2.85%) |
Aug 10, 2026 11w ago | 425 | $6.73 | awaiting T+60 | — | $5.22 (+22.36%) |
Aug 4, 2026 12w ago | 425 | $5.78 | awaiting T+60 | — | $5.22 (−9.60%) |
Aug 3, 2026 12w ago | Insider Buy | $5.78 | awaiting T+60 | — | $5.22 (−9.60%) |
Jul 29, 2026 12w ago | Insider Buy | $5.03 $4.98 | ▼ −0.99% | ▼ −3.46% | $5.22 (+3.88%) |
Jul 14, 2026 15w ago | 425 / 8-K | $6.58 $6.56 | ▼ −0.30% | ▼ −3.68% | $5.22 (−20.59%) |
Jul 14, 2026 15w ago | 8-K | $6.58 $6.56 | ▲ +0.30% | ▲ +3.68% | $5.22 (+20.59%) |
Jun 1, 2026 21w ago | 8-K | $3.38 $5.91 | ▲ +74.85% | ▲ +73.62% | $5.22 (+54.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers